Investment firm Canary has officially submitted an S-1 Registration Statement to U.S. regulators for an Injective (INJ) Exchange-Traded Fund (ETF).
This filing represents a concrete step forward in the potential launch of this new investment vehicle, offering traditional markets a structured way to gain exposure to the Injective token.
The S-1 filing is a necessary regulatory requirement preceding the launch of an ETF, signaling Canary’s commitment to bringing this cryptocurrency investment product to market within the established securities framework.
This pursuit aligns with the broader industry trend towards creating regulated, accessible investment opportunities centered on specific digital assets.